EcoDrugPlus

Ensembl ID : ENSBGRG00000008565
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSBGRG00000019719
Gene Symbol: -
Cross references: -
312 Possible Orthologues:

Ensembl ID : ENSBGRG00000020003
Gene Symbol: -
Cross references: -
375 Possible Orthologues:

Ensembl ID : ENSBGRG00000008360
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSBGRG00000007921
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSBGRG00000007887
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSBGRG00000007840
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSBGRG00000007555
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSBGRG00000007210
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSBGRG00000021181
Gene Symbol: -
Cross references: -
87 Possible Orthologues:

Ensembl ID : ENSBGRG00000022004
Gene Symbol: -
Cross references: -
699 Possible Orthologues:

Ensembl ID : ENSBGRG00000022832
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).